Datang International Details RMB1.54 Billion Capital Injection for Key Nuclear Projects

The latest announcement is out from Datang International Power Generation Co ( (HK:0991) ).

Datang International Power Generation Co., Ltd. has provided further details on a previously announced RMB1.542 billion capital increase, jointly injected with CDC into Datang Nuclear Company, to fund several major nuclear power projects in China. The funds will cover basic construction costs of approximately RMB856.21 million for the Liaoning Xudabao Nuclear Power Project and RMB616.98 million for the Ningde Phase II Nuclear Power Project, as well as RMB69.17 million in preliminary development, engineering and management expenses for the Guangdong Yangxi Nuclear Power Project. The board, including independent non-executive directors, considers the capital increase to be on normal commercial terms, fair and reasonable, and in the interests of the company and its shareholders, underscoring Datang’s strategic commitment to expanding its nuclear power footprint and supporting long-term capacity growth.

The most recent analyst rating on (HK:0991) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Datang International Power Generation Co stock, see the HK:0991 Stock Forecast page.

More about Datang International Power Generation Co

Datang International Power Generation Co., Ltd. is a Sino-foreign joint stock company incorporated in the People’s Republic of China and listed in Hong Kong, primarily engaged in power generation. The company operates a diversified portfolio that increasingly includes nuclear power assets through its holdings in Datang Nuclear Company, supporting China’s broader energy transition and infrastructure development.

Average Trading Volume: 24,641,688

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$64.37B

See more insights into 0991 stock on TipRanks’ Stock Analysis page.